BioSpace News Archive

Prime Healthcare owns and operates 45 acute care hospitals in 14 states.

Notes With 50% Warrants Exercisable at $0.35 Per Share

Presentations span 21 research areas with five oral presentations

Arena Pharmaceuticals, Inc presented preclinical data for its recently announced investigational compound, APD418, a first-in-class calcium-independent myofilament derepressor (CMD), ß3 adrenergic receptor (AdrR) selective antagonist, at the American Heart Association Scientific Sessions 2018.

Ardelyx Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tenapanor for the treatment of patients with irritable bowel syndrome with constipation (IBS-C).

Sonendo, announced that the company will present at the Jefferies 2018 London Healthcare Conference at 4:40 PM GMT on Thursday, November 15, 2018.

Recipients of this honor is decided by a distinguished panel of biotechnology experts, including CEOs, CIOs, VCs analysts and the editorial board of StartupCity magazine.

Presented at the 18th Annual Diabetes Technology Meeting, the study found that patients treated using Glytec’s solution had 73.2% less hypoglycemia and no bounce backs once transferred from a CCU to a general ward.

Sigilon Therapeutics today announced the appointment of four new members of its senior management team as the company prepares to advance its lead therapeutic candidate into clinical trials. Deya Corzo, M.D., FACMG, joins the company as Chief Medical Officer; Olivia G. Kelly, Ph.D., is Vice President of Islet Cell Therapy Research; Martha Rook, Ph.D., is Head of Manufacturing; and Vanya Sagar joins as Vice President of HR.

PARSIPPANY, N.J.--(BUSINESS WIRE)-- Ferring Pharmaceuticals announced today that it has signed an agreement to acquire from INVO Bioscience Inc. (OTCQB:IVOB) the exclusive U.S. commercialization rights for the INVOcell intravaginal culture (IVC) system, which comprises the INVOcell IVC device, retention device, and holding block.